Degradable and Removable Tough Adhesive Hydrogels
Source abstract
Abstract
The development of tough adhesive hydrogels has enabled unprecedented adhesion to wet and moving tissue surfaces throughout the body, but they are typically composed of nondegradable components. Here, a family of degradable tough adhesive hydrogels containing ≈90% water by incorporating covalently networked degradable crosslinkers and hydrolyzable ionically crosslinked main‐chain polymers is developed. Mechanical toughness, adhesion, and degradation of these new formulations are tested in both accelerated in vitro conditions and up to 16 weeks in vivo. These degradable tough adhesives are engineered with equivalent mechanical and adhesive properties to nondegradable tough adhesives, capable of achieving stretches >20 times their initial length, fracture energies >6 kJ m−2, and adhesion energies >1000 J m−2. All degradable systems show complete degradation within 2 weeks under accelerated aging conditions in vitro and weeks to months in vivo depending on the degradable crosslinker selected. Excellent biocompatibility is observed for all groups after 1, 2, 4, 8, and 16 weeks of implantation, with minimal fibrous encapsulation and no signs of organ toxicity. On‐demand removal of the adhesive is achieved with treatment of chemical agents which do not cause damage to underlying skin tissue in mice. The broad versatility of this family of adhesives provides the foundation for numerous in vivo indications.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Surgical Sutures and Adhesives · Hydrogels: synthesis, properties, applications · 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
John A. Paulson School of Engineering and Applied Sciences Harvard University Cambridge MA 02138 USA
Wyss Institute for Biologically Inspired Engineering Harvard University Boston MA 02115 USA
Department of Mechanical Engineering University of Puerto Rico‐Mayaguez Puerto Rico 00682 USA
Funding
National Institute on Aging
References (57)
Show source-provided references
1. 10.1002/adma.20180669510.1002/adma.201806695 ↗
2. 10.1038/nature1140910.1038/nature11409 ↗
3. 10.1126/science.aah636210.1126/science.aah6362 ↗
4. 10.1039/C3SM52272E10.1039/C3SM52272E ↗
5. 10.1126/sciadv.aaw396310.1126/sciadv.aaw3963 ↗
6. 10.1016/j.jpedsurg.2020.09.03010.1016/j.jpedsurg.2020.09.030 ↗
7. 10.1016/j.biomaterials.2018.07.03110.1016/j.biomaterials.2018.07.031 ↗
8. 10.1021/bp010070p10.1021/bp010070p ↗
9. 10.1016/j.biomaterials.2015.08.04510.1016/j.biomaterials.2015.08.045 ↗
10. 10.1021/bm990017d10.1021/bm990017d ↗
11. 10.1016/j.biomaterials.2013.11.04410.1016/j.biomaterials.2013.11.044 ↗
12. 10.1016/j.carbpol.2009.09.02010.1016/j.carbpol.2009.09.020 ↗
13. 10.1016/S0142-9612(00)00116-210.1016/S0142-9612(00)00116-2 ↗
14. Loncarevic A. · J. Tissue Repair Regener. · 2017 · 1 · 12
15. 10.1080/1023666970803277510.1080/10236669708032775 ↗
16. 10.1002/app.3427810.1002/app.34278 ↗
17. 10.1038/s41586-019-1710-510.1038/s41586-019-1710-5 ↗
18. 10.1002/adma.20200162810.1002/adma.202001628 ↗
19. Yang H. · ACS Appl. Bio Mater. · 2019 · 2 · 5
20. 10.1002/jbm.a.3509610.1002/jbm.a.35096 ↗
21. Hunter R. L. · Ann. Clin. Lab. Sci. · 2010 · 40 · 115
22. 10.2174/187220831120603020010.2174/1872208311206030200 ↗
23. 10.1002/adhm.20170146910.1002/adhm.201701469 ↗
24. 10.1016/j.cardiores.2005.12.00210.1016/j.cardiores.2005.12.002 ↗
25. 10.1016/S0945-053X(01)00172-X10.1016/S0945-053X(01)00172-X ↗
26. 10.1080/1040923029077154610.1080/10409230290771546 ↗
27. 10.1002/bit.1060510.1002/bit.10605 ↗
28. 10.1046/j.1524-475X.1999.00079.x10.1046/j.1524-475X.1999.00079.x ↗
29. 10.1021/bm049508a10.1021/bm049508a ↗
30. 10.1046/j.1365-2796.1997.00171.x10.1046/j.1365-2796.1997.00171.x ↗
31. 10.1016/S0021-9258(18)52919-710.1016/S0021-9258(18)52919-7 ↗
32. 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B ↗
33. 10.1083/jcb.122.1.25710.1083/jcb.122.1.257 ↗
34. 10.1016/j.biomaterials.2007.11.04710.1016/j.biomaterials.2007.11.047 ↗
35. 10.1074/jbc.M60835820010.1074/jbc.M608358200 ↗
36. 10.1038/s41578-019-0171-710.1038/s41578-019-0171-7 ↗
37. 10.1016/j.jtcvs.2018.08.04310.1016/j.jtcvs.2018.08.043 ↗
38. 10.1016/j.jtcvs.2004.07.04610.1016/j.jtcvs.2004.07.046 ↗
39. 10.1510/icvts.2011.27636010.1510/icvts.2011.276360 ↗
40. 10.1097/BRS.0b013e3181a56a2110.1097/BRS.0b013e3181a56a21 ↗
41. 10.14245/kjs.2013.10.1.4410.14245/kjs.2013.10.1.44 ↗
42. 10.1055/s-0030-127051710.1055/s-0030-1270517 ↗
43. 10.3390/ijerph1009384310.3390/ijerph10093843 ↗
44. 10.1080/1091581059095384210.1080/10915810590953842 ↗
45. 10.1007/s11356-014-3556-610.1007/s11356-014-3556-6 ↗
46. Sec. 172.255 Polyacrylamide. 2019 FDA CFR 21 https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=172.255%26SearchTerm=polyacrylamide(accessed: August 2020).
47. Sec. 872.3480 Polyacrylamide polymer (modified cationic) denture adhesive. 2019 FDA Subpart D–Prosthetic Devices CFR‐21 https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=872.3480(accessed: August 2020).
48. G. E.Deckner WO1993007856A1 1993.
49. 10.1016/j.biomaterials.2013.06.06110.1016/j.biomaterials.2013.06.061 ↗
50. 10.1111/j.1464-410X.2006.06205.x10.1111/j.1464-410X.2006.06205.x ↗
51. 10.1007/s00192-015-2781-y10.1007/s00192-015-2781-y ↗
52. FDA 2003 Summary of Safety and Effectiveness Data PMA: P030039 1475 Report https://www.accessdata.fda.gov/cdrh_docs/pdf3/P030039b.pdf(accessed: August 2020).
53. FDA 1999 Summary of Safety and Effectiveness. PMA: P990009 1476 Report https://www.accessdata.fda.gov/cdrh_docs/pdf/P990009B.pdf(accessed: August 2020).
54. FDA 2009 Summary of Safety and Effectiveness Data. PMA: P080013 1477 Report https://www.accessdata.fda.gov/cdrh_docs/pdf8/P080013b.pdf(accessed: August 2020).
55. FDA 1998 Highlights of Prescribing Information: TISSEEL 1478 Report https://www.fda.gov/media/71674/download(accessed: August 2020).
56. 10.1016/j.biomaterials.2004.06.04410.1016/j.biomaterials.2004.06.044 ↗
57. F.Al‐Taher 2012 Analysis of acrylamide in french fries using Agilent Bond Elut QuEChERS AOAC kit and LC/MS/MS 1469 Report https://www.agilent.com/cs/library/applications/5990-5940EN.pdf(accessed: August 2020).